Optical coherence tomography angiography

Last updated

Optical coherence tomography angiography (OCTA) [1] [2] [3] [4] is a non-invasive imaging technique based on optical coherence tomography (OCT) developed to visualize vascular networks in the human retina, [4] [5] [6] [7] [8] [9] choroid, [10] [11] [12] [13] skin [14] and various animal models. [15] [16] [17] OCTA may make use of speckle variance optical coherence tomography.

Contents

OCTA uses motion contrast between cross-sectional OCT scans (B-frames) to differentiate blood flow from static tissue, enabling imaging of vascular anatomy. [4] [18] To correct for patient movement during scanning, bulk tissue changes in the axial direction are eliminated, ensuring that all detected changes are due to red blood cell movement. [18] This form of OCT requires a very high sampling density in order to achieve the resolution needed to detect the tiny capillaries found in the retina. [18] [19] This has allowed OCTA to obtain detailed images of retinal vasculature in the human retina [20] and become widely used clinically to diagnose a variety of eye diseases, such as age related macular degeneration (AMD), [21] diabetic retinopathy (DR), [22] [23] artery and vein occlusions, and glaucoma. [24] [18]

Medical uses

While conventional dye-based angiography is still the common gold standard, OCTA has been evaluated and used across many diseases. [4] [5] [25] OCTA was first introduced in clinical eyecare 2014. [26]

OCTA has applications in several diseases, including leading causes of blindness such as glaucoma [24] and age-related macular degeneration. [27] In diabetic retinopathy (DR), OCTA was shown to resolve previously established markers of severe disease (i.e., vitreous proliferation). Moreover, OCTA was shown to provide a plethora of additional biomarkers including subclinical loss of vessel density. [28] [29] [30] [31] Thus, OCTA may offer in future the potential to monitor the progression of DR at an earlier, pre-clinical state. Similarly, OCTA was shown to provide more refined information compared to dye-based angiography in other vascular occlusive diseases such as central (or branch) retinal vein occlusion. [32] [33]

How it works

OCTA detects moving particles (red blood cells) by comparing sequential B-scans at the same cross-sectional location. To simply put it, the backscattered light reflected back from static samples would remain the same over multiple B-scans while the backscattered light reflected back from moving samples would fluctuate. Multiple algorithms have been proposed and utilized to contrast such motion signals from static signals in various biological tissues. [34] [35] [36] [3] [37] [38]

Calculating blood flow

An algorithm developed by Jia et al. [1] is used to determine blood flow in the retina. The split-spectrum amplitude decorrelation angiography (SSADA) algorithm calculates the decorrelation in the reflected light that is detected by the OCT device.

The blood vessels are where the most decorrelation occurs allowing them to be visualized, while static tissue has low decorrelation values. [39] The equation takes into account fluctuations of the received signal amplitude or intensity over time. Greater fluctuations receive a greater decorrelation value and indicate more movement.

A significant challenge when trying to image the eye is patient movement and saccadic movement of the eye. Movement introduces a lot of noise into the signal making tiny vessels impossible to distinguish. One approach to decreasing the influence of movement on signal detection is to shorten the scanning time. A short scan time prevents too much patient movement during signal acquisition. With the development of Fourier-domain OCT, spectral-domain OCT, and swept source signal acquisition time was greatly improved making OCTA possible. [40] OCTA scan time is now around three seconds, however, saccadic eye movement still causes a low signal-to-noise ratio. This is where SSADA proves to be very advantageous as it is able to greatly improve SNR by averaging the decorrelation across the number of B-scans, making the microvasculature of the retina visible. [39]

History

Initial efforts to measure blood flow using OCT utilized the Doppler effect. [41] [42] By comparing the phase of successive A-mode scans, the velocity of blood flow can be determined via the Doppler equation. This was deemed Optical Doppler Tomography; the development of spectral domain OCT (SD-OCT) and swept-source OCT (SS-OCT) greatly improved scan times since this phase information was readily accessible. Still, Doppler techniques were fundamentally limited by bulk eye motion artefacts, especially as longer scan times became important for increasing sensitivity. [43] In the mid-2000s systems began compensating for bulk eye motion, which significantly reduced motion artefacts. Systems also began to measure the variance and power of the Doppler phase between successive A-mode and B-mode scans; later it was shown that successive B-mode scans must be corrected for motion and the phase variance data must be thresholded to remove bulk eye motion distortion. [43] [2] [44] [45]

By 2012, split spectrum amplitude decorrelation was shown to be effective at increasing SNR and decreasing motion artefacts. [37] Commercial OCT-A devices also emerged around this time, beginning with the OptoVue AngioVue in 2014 (SD-OCT) and the Topcon Atlantis/Triton soon after (SS-OCT). [43]

Other angiography techniques

The most common angiographic techniques were fluorescein (FA) or indocyanine green angiography (ICGA), which both involve the use of an injectable dye. Intravenous dye injection is time-consuming and can have adverse side effects. Furthermore, the edges of the capillaries can become blurred due to dye leakage and imaging of the retina can only be 2D when using this method. [40] With OCTA, dye injection is not needed making the imaging process faster and more comfortable while at the same time improving the quality of the image.

The current gold standards of angiography, fluorescein angiography (FA) and indocyanine green angiography (ICGA), both require dye to be injected. [46] [47]

OCTA does not need dye but is susceptible to motion artefacts. The dyes used in FA and ICGA can cause nausea, vomiting, and general discomfort, and only have an effective lifetime on the order of a few minutes. [48]

From a physics perspective, both dye-based methods utilize the phenomenon of fluorescence. For FA, this corresponds to an excitation wavelength of blue (around 470 nm) and an emission wavelength near yellow (520 nm). [49] For IGCA, the newer method, the excitation wavelength is between 750 and 800 nm while emission occurs above 800 nm. [50]

Related Research Articles

<span class="mw-page-title-main">Diabetic retinopathy</span> Medical condition

Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness in developed countries.

<span class="mw-page-title-main">Microangiopathy</span> Medical condition

Microangiopathy is a disease of the microvessels, small blood vessels in the microcirculation. It can be contrasted to macroangiopathies such as atherosclerosis, where large and medium-sized arteries are primarily affected.

The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is "to eliminate vision loss and improve quality of life through vision research." NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.

<span class="mw-page-title-main">Optical coherence tomography</span> Imaging technique

Optical coherence tomography (OCT) is an imaging technique that uses interferometry with short-coherence-length light to obtain micrometer-level depth resolution and uses transverse scanning of the light beam to form two- and three-dimensional images from light reflected from within biological tissue or other scattering media. Short-coherence-length light can be obtained using a superluminescent diode (SLD) with a broad spectral bandwidth or a broadly tunable laser with narrow linewidth. The first demonstration of OCT imaging was published by a team from MIT and Harvard Medical School in a 1991 article in the journal Science. The article introduced the term “OCT” to credit its derivation from optical coherence-domain reflectometry, in which the axial resolution is based on temporal coherence. The first demonstrations of in vivo OCT imaging quickly followed.

<span class="mw-page-title-main">Scanning laser ophthalmoscopy</span>

Scanning laser ophthalmoscopy (SLO) is a method of examination of the eye. It uses the technique of confocal laser scanning microscopy for diagnostic imaging of the retina or cornea of the human eye.

<span class="mw-page-title-main">Epiretinal membrane</span> Eye disease

Epiretinal membrane or macular pucker is a disease of the eye in response to changes in the vitreous humor or more rarely, diabetes. Sometimes, as a result of immune system response to protect the retina, cells converge in the macular area as the vitreous ages and pulls away in posterior vitreous detachment (PVD).

<span class="mw-page-title-main">Macular hypoplasia</span> Medical condition

Macular hypoplasia is a rare medical condition involving the underdevelopment of the macula, a small area on the retina responsible for seeing in detail and sensing light. Macular hypoplasia is often associated with albinism.

Charcot–Bouchard aneurysms are aneurysms of the brain vasculature which occur in small blood vessels. Charcot–Bouchard aneurysms are most often located in the lenticulostriate vessels of the basal ganglia and are associated with chronic hypertension. Charcot–Bouchard aneurysms are a common cause of cerebral hemorrhage.

<span class="mw-page-title-main">Acute posterior multifocal placoid pigment epitheliopathy</span> Eye disease causing lesions in retina

Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is an acquired inflammatory uveitis that belongs to the heterogenous group of white dot syndromes in which light-coloured (yellowish-white) lesions begin to form in the macular area of the retina. Early in the course of the disease, the lesions cause acute and marked vision loss that ranges from mild to severe but is usually transient in nature. APMPPE is classified as an inflammatory disorder that is usually bilateral and acute in onset but self-limiting. The lesions leave behind some pigmentation, but visual acuity eventually improves even without any treatment.

<span class="mw-page-title-main">Fundus photography</span> Medical imaging of the eyes

Fundus photography involves photographing the rear of an eye, also known as the fundus. Specialized fundus cameras consisting of an intricate microscope attached to a flash enabled camera are used in fundus photography. The main structures that can be visualized on a fundus photo are the central and peripheral retina, optic disc and macula. Fundus photography can be performed with colored filters, or with specialized dyes including fluorescein and indocyanine green.

<span class="mw-page-title-main">Choroidal neovascularization</span> Creation of new blood vessels in the choroid layer of the eye

Choroidal neovascularization (CNV) is the creation of new blood vessels in the choroid layer of the eye. Choroidal neovascularization is a common cause of neovascular degenerative maculopathy commonly exacerbated by extreme myopia, malignant myopic degeneration, or age-related developments.

<span class="mw-page-title-main">Macular telangiectasia</span> Disease of the retina affecting central vision

Macular telangiectasia is a condition of the retina, the light-sensing tissue at the back of the eye that causes gradual deterioration of central vision, interfering with tasks such as reading and driving.

Berlin's edema a common condition caused by blunt injury to the eye. It is characterized by decreased vision in the injured eye a few hours after the injury. Under examination the retina appears opaque and white in colour in the periphery but the blood vessels are normally seen along with "cherry red spot" in the foveal region. This whitening is indicative of cell damage, which occurs in the retinal pigment epithelium and outer segment layer of photoreceptors. Damage to the outer segment often results in photoreceptor death through uncertain mechanisms. Usually there is no leakage of fluid and therefore it is not considered a true edema. The choroidal fluorescence in fluorescent angiography is absent. Visual acuity ranges from 20/20 to 20/400.

<span class="mw-page-title-main">Branch retinal vein occlusion</span> Medical condition

Branch retinal vein occlusion is a common retinal vascular disease of the elderly. It is caused by the occlusion of one of the branches of central retinal vein.

<span class="mw-page-title-main">Teleophthalmology</span>

Teleophthalmology is a branch of telemedicine that delivers eye care through digital medical equipment and telecommunications technology. Today, applications of teleophthalmology encompass access to eye specialists for patients in remote areas, ophthalmic disease screening, diagnosis and monitoring; as well as distant learning.

<span class="mw-page-title-main">Intracoronary optical coherence tomography</span>

Intracoronary optical coherence tomography (OCT) is a catheter-based imaging application of optical coherence tomography. Currently prospective trials demonstrate OCT alters morbidity and/or mortality in coronary stenting and cervical cancer screening as discussed below.

Geographic atrophy (GA), also known as atrophic age-related macular degeneration (AMD) or advanced dry AMD, is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retinal tissue (photoreceptors, retinal pigment epithelium, choriocapillaris) which can lead to a loss of visual function over time. It is estimated that GA affects over 5 million people worldwide and approximately 1 million patients in the US, which is similar to the prevalence of neovascular (wet) AMD, the other advanced form of the disease.

Speckle variance optical coherence tomography (SV-OCT) is an imaging algorithm for functional optical imaging. Optical coherence tomography is an imaging modality that uses low-coherence interferometry to obtain high resolution, depth-resolved volumetric images. OCT can be used to capture functional images of blood flow, a technique known as optical coherence tomography angiography (OCT-A). SV-OCT is one method for OCT-A that uses the variance of consecutively acquired images to detect flow at the micron scale. SV-OCT can be used to measure the microvasculature of tissue. In particular, it is useful in ophthalmology for visualizing blood flow in retinal and choroidal regions of the eye, which can provide information on the pathophysiology of diseases.

Sickle cell retinopathy can be defined as retinal changes due to blood vessel damage in the eye of a person with a background of sickle cell disease. It can likely progress to loss of vision in late stages due to vitreous hemorrhage or retinal detachment. Sickle cell disease is a structural red blood cell disorder leading to consequences in multiple systems. It is characterized by chronic red blood cell destruction, vascular injury, and tissue ischemia causing damage to the brain, eyes, heart, lungs, kidneys, spleen, and musculoskeletal system.

Cynthia Ann Toth is an American ophthalmologist who is Distinguished Professor of Ophthalmology at Duke University. Toth has pioneered the use of optical coherence tomography to better understand, diagnose and treat macular disease. She was awarded the 2021 Retina Research Foundation Pyron Award.

References

  1. 1 2 Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. (February 2012). "Split-spectrum amplitude-decorrelation angiography with optical coherence tomography". Optics Express. 20 (4): 4710–4725. Bibcode:2012OExpr..20.4710J. doi:10.1364/OE.20.004710. PMC   3381646 . PMID   22418228.
  2. 1 2 Makita S, Hong Y, Yamanari M, Yatagai T, Yasuno Y (August 2006). "Optical coherence angiography". Optics Express. 14 (17): 7821–7840. Bibcode:2006OExpr..14.7821M. doi:10.1364/oe.14.007821. hdl: 2241/108149 . PMID   19529151.
  3. 1 2 Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A (April 2007). "Three dimensional optical angiography". Optics Express. 15 (7): 4083–4097. Bibcode:2007OExpr..15.4083W. doi: 10.1364/OE.15.004083 . PMID   19532651.
  4. 1 2 3 4 Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, et al. (May 2015). "Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye". Proceedings of the National Academy of Sciences of the United States of America. 112 (18): E2395–E2402. Bibcode:2015PNAS..112E2395J. doi: 10.1073/pnas.1500185112 . PMC   4426471 . PMID   25897021.
  5. 1 2 Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, et al. (July 2016). "Optical Coherence Tomography Angiography". Investigative Ophthalmology & Visual Science. 57 (9): OCT27–OCT36. doi:10.1167/iovs.15-19043. PMC   4968919 . PMID   27409483.
  6. ↑ Hormel TT, Jia Y, Jian Y, Hwang TS, Bailey ST, Pennesi ME, et al. (January 2021). "Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography". Progress in Retinal and Eye Research. 80: 100878. doi:10.1016/j.preteyeres.2020.100878. PMC   7855241 . PMID   32712135.
  7. ↑ Kashani AH, Lee SY, Moshfeghi A, Durbin MK, Puliafito CA (November 2015). "Optical Coherence Tomography Angiography of Retinal Venous Occlusion". Retina. 35 (11): 2323–2331. doi:10.1097/iae.0000000000000811. PMID   26457395. S2CID   26880837.
  8. ↑ Spaide RF, Klancnik JM, Cooney MJ (January 2015). "Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography". JAMA Ophthalmology. 133 (1): 45–50. doi: 10.1001/jamaophthalmol.2014.3616 . PMID   25317632.
  9. ↑ Gildea D (October 2019). "The diagnostic value of optical coherence tomography angiography in diabetic retinopathy: a systematic review". International Ophthalmology. 39 (10): 2413–2433. doi: 10.1007/s10792-018-1034-8 . PMID   30382465.
  10. ↑ Camino A, Guo Y, You Q, Wang J, Huang D, Bailey ST, Jia Y (October 2019). "Detecting and measuring areas of choriocapillaris low perfusion in intermediate, non-neovascular age-related macular degeneration". Neurophotonics. 6 (4): 041108. doi:10.1117/1.NPh.6.4.041108. PMC   6739623 . PMID   31528658.
  11. ↑ You QS, Chan JC, Ng AL, Choy BK, Shih KC, Cheung JJ, et al. (November 2019). "Macular Vessel Density Measured With Optical Coherence Tomography Angiography and Its Associations in a Large Population-Based Study". Investigative Ophthalmology & Visual Science. 60 (14): 4830–4837. doi: 10.1167/iovs.19-28137 . PMID   31747685. S2CID   208215569.
  12. ↑ Levison AL, Baynes KM, Lowder CY, Kaiser PK, Srivastava SK (May 2017). "Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis". The British Journal of Ophthalmology. 101 (5): 616–622. doi:10.1136/bjophthalmol-2016-308806. PMID   27539089. S2CID   29133966.
  13. ↑ Chu Z, Weinstein JE, Wang RK, Pepple KL (October 2020). "Quantitative Analysis of the Choriocapillaris in Uveitis Using En Face Swept-Source Optical Coherence Tomography Angiography". American Journal of Ophthalmology. 218: 17–27. doi:10.1016/j.ajo.2020.05.006. PMC   7529782 . PMID   32413411.
  14. ↑ Xu J, Song S, Men S, Wang RK (November 2017). "Long ranging swept-source optical coherence tomography-based angiography outperforms its spectral-domain counterpart in imaging human skin microcirculations". Journal of Biomedical Optics. 22 (11): 1–11. Bibcode:2017JBO....22k6007X. doi: 10.1117/1.jbo.22.11.116007 . PMC   5712670 . PMID   29185292.
  15. ↑ Fischer MD, Huber G, Beck SC, Tanimoto N, Muehlfriedel R, Fahl E, et al. (October 2009). "Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography". PLOS ONE. 4 (10): e7507. Bibcode:2009PLoSO...4.7507F. doi: 10.1371/journal.pone.0007507 . PMC   2759518 . PMID   19838301.
  16. ↑ Merkle CW, Zhu J, Bernucci MT, Srinivasan VJ (November 2019). "Dynamic Contrast Optical Coherence Tomography reveals laminar microvascular hemodynamics in the mouse neocortex in vivo". NeuroImage. 202: 116067. doi: 10.1016/j.neuroimage.2019.116067 . PMC   6819266 . PMID   31394180.
  17. ↑ Chen S, Liu Q, Shu X, Soetikno B, Tong S, Zhang HF (September 2016). "Imaging hemodynamic response after ischemic stroke in mouse cortex using visible-light optical coherence tomography". Biomedical Optics Express. 7 (9): 3377–3389. doi:10.1364/boe.7.003377. PMC   5030017 . PMID   27699105.
  18. 1 2 3 4 de Carlo TE, Romano A, Waheed NK, Duker JS (April 2015). "A review of optical coherence tomography angiography (OCTA)". International Journal of Retina and Vitreous. 1 (1): 5. doi: 10.1186/s40942-015-0005-8 . PMC   5066513 . PMID   27847598.
  19. ↑ Drexler W, Liu M, Kumar A, Kamali T, Unterhuber A, Leitgeb RA (2014). "Optical coherence tomography today: speed, contrast, and multimodality". Journal of Biomedical Optics. 19 (7): 071412. Bibcode:2014JBO....19g1412D. doi: 10.1117/1.jbo.19.7.071412 . PMID   25079820.
  20. ↑ Campbell JP, Zhang M, Hwang TS, Bailey ST, Wilson DJ, Jia Y, Huang D (February 2017). "Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography". Scientific Reports. 7 (1): 42201. Bibcode:2017NatSR...742201C. doi:10.1038/srep42201. PMC   5301488 . PMID   28186181.
  21. ↑ Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. (July 2014). "Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration". Ophthalmology. 121 (7): 1435–1444. doi:10.1016/j.ophtha.2014.01.034. PMC   4082740 . PMID   24679442.
  22. ↑ Hwang TS, Jia Y, Gao SS, Bailey ST, Lauer AK, Flaxel CJ, et al. (November 2015). "Optical Coherence Tomography Angiography Features of Diabetic Retinopathy". Retina. 35 (11): 2371–2376. doi:10.1097/IAE.0000000000000716. PMC   4623938 . PMID   26308529.
  23. ↑ Hwang TS, Gao SS, Liu L, Lauer AK, Bailey ST, Flaxel CJ, et al. (April 2016). "Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic Retinopathy". JAMA Ophthalmology. 134 (4): 367–373. doi:10.1001/jamaophthalmol.2015.5658. PMC   4978127 . PMID   26795548.
  24. 1 2 Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, et al. (July 2014). "Optical coherence tomography angiography of optic disc perfusion in glaucoma". Ophthalmology. 121 (7): 1322–1332. doi:10.1016/j.ophtha.2014.01.021. PMC   4082728 . PMID   24629312.
  25. ↑ Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. (September 2017). "Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications". Progress in Retinal and Eye Research. 60: 66–100. doi:10.1016/j.preteyeres.2017.07.002. PMC   5600872 . PMID   28760677.
  26. ↑ Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (May 2018). "Optical coherence tomography angiography". Progress in Retinal and Eye Research. 64: 1–55. doi:10.1016/j.preteyeres.2017.11.003. PMC   6404988 . PMID   29229445.
  27. ↑ Jia, Yali; Bailey, Steven T.; Wilson, David J.; Tan, Ou; Klein, Michael L.; Flaxel, Christina J.; Potsaid, Benjamin; Liu, Jonathan J.; Lu, Chen D.; Kraus, Martin F.; Fujimoto, James G.; Huang, David (2014-07). "Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration". Ophthalmology. 121 (7): 1435–1444. doi:10.1016/j.ophtha.2014.01.034. PMC  4082740. PMID  24679442.
  28. ↑ Papakostas TD, Kiss S (August 2018). "Optical Coherence Tomography Angiography to Evaluate Ischemia in Diabetic Eyes". JAMA Ophthalmology. 136 (8): 936–937. doi:10.1001/jamaophthalmol.2018.2256. PMID   29902300. S2CID   49213827.
  29. ↑ Wang B, Camino A, Pi S, Guo Y, Wang J, Huang D, et al. (July 2019). "Three-dimensional structural and angiographic evaluation of foveal ischemia in diabetic retinopathy: method and validation". Biomedical Optics Express. 10 (7): 3522–3532. doi:10.1364/BOE.10.003522. PMC   6640826 . PMID   31360604.
  30. ↑ Al-Sheikh M, Akil H, Pfau M, Sadda SR (July 2016). "Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy". Investigative Ophthalmology & Visual Science. 57 (8): 3907–3913. doi: 10.1167/iovs.16-19570 . PMID   27472076.
  31. ↑ Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S (June 2016). "Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische und Experimentelle Ophthalmologie. 254 (6): 1051–1058. doi:10.1007/s00417-015-3148-2. PMC   4884570 . PMID   26338819.
  32. ↑ Wons J, Pfau M, Wirth MA, Freiberg FJ, Becker MD, Michels S (2016). "Optical Coherence Tomography Angiography of the Foveal Avascular Zone in Retinal Vein Occlusion". Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 235 (4): 195–202. doi:10.1159/000445482. PMID   27160007. S2CID   22808467.
  33. ↑ Tang W, Guo J, Zhuang X, Zhang T, Wang L, Wang K, et al. (February 2021). "Wide-Field Swept-Source Optical Coherence Tomography Angiography Analysis of the Periarterial Capillary-Free Zone in Branch Retinal Vein Occlusion". Translational Vision Science & Technology. 10 (2): 9. doi:10.1167/tvst.10.2.9. PMC   7881276 . PMID   34003897.
  34. ↑ Enfield J, Jonathan E, Leahy M (April 2011). "In vivo imaging of the microcirculation of the volar forearm using correlation mapping optical coherence tomography (cmOCT)". Biomedical Optics Express. 2 (5): 1184–1193. doi:10.1364/boe.2.001184. PMC   3087575 . PMID   21559130.
  35. ↑ Barton J, Stromski S (July 2005). "Flow measurement without phase information in optical coherence tomography images". Optics Express. 13 (14): 5234–5239. Bibcode:2005OExpr..13.5234B. doi: 10.1364/OPEX.13.005234 . PMID   19498514.
  36. ↑ Fingler J, Zawadzki RJ, Werner JS, Schwartz D, Fraser SE (November 2009). "Volumetric microvascular imaging of human retina using optical coherence tomography with a novel motion contrast technique". Optics Express. 17 (24): 22190–22200. Bibcode:2009OExpr..1722190F. doi:10.1364/OE.17.022190. PMC   2791341 . PMID   19997465.
  37. 1 2 Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. (February 2012). "Split-spectrum amplitude-decorrelation angiography with optical coherence tomography". Optics Express. 20 (4): 4710–4725. Bibcode:2012OExpr..20.4710J. doi:10.1364/oe.20.004710. hdl: 1721.1/73109 . PMC   3381646 . PMID   22418228. S2CID   13838091.
  38. ↑ Ryu G, Park D, Lim J, van Hemert J, Sagong M (May 2021). "Macular Microvascular Changes and Their Correlation With Peripheral Nonperfusion in Branch Retinal Vein Occlusion". American Journal of Ophthalmology. 225: 57–68. doi:10.1016/j.ajo.2020.12.026. PMID   33412121. S2CID   231192745.
  39. 1 2 Koustenis A, Harris A, Gross J, Januleviciene I, Shah A, Siesky B (January 2017). "Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research". The British Journal of Ophthalmology. 101 (1): 16–20. doi:10.1136/bjophthalmol-2016-309389. PMID   27707691. S2CID   11456379.
  40. 1 2 Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, et al. (July 2016). "Optical Coherence Tomography Angiography". Investigative Ophthalmology & Visual Science. 57 (9): OCT27–OCT36. doi:10.1167/iovs.15-19043. PMC   4968919 . PMID   27409483.
  41. ↑ Izatt JA, Kulkarni MD, Yazdanfar S, Barton JK, Welch AJ (September 1997). "In vivo bidirectional color Doppler flow imaging of picoliter blood volumes using optical coherence tomography". Optics Letters. 22 (18): 1439–1441. Bibcode:1997OptL...22.1439I. doi:10.1364/ol.22.001439. PMID   18188263.
  42. ↑ Chen Z, Milner TE, Srinivas S, Wang X, Malekafzali A, van Gemert MJ, Nelson JS (July 1997). "Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography". Optics Letters. 22 (14): 1119–1121. Bibcode:1997OptL...22.1119C. doi:10.1364/ol.22.001119. PMID   18185770. S2CID   30205866.
  43. 1 2 3 Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (May 2018). "Optical coherence tomography angiography". Progress in Retinal and Eye Research. 64: 1–55. doi: 10.1016/j.preteyeres.2017.11.003 . PMC   6404988 . PMID   29229445.
  44. ↑ Fingler J, Zawadzki RJ, Werner JS, Schwartz D, Fraser SE (November 2009). "Volumetric microvascular imaging of human retina using optical coherence tomography with a novel motion contrast technique". Optics Express. 17 (24): 22190–22200. Bibcode:2009OExpr..1722190F. doi:10.1364/oe.17.022190. PMC   2791341 . PMID   19997465.
  45. ↑ Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A (April 2007). "Three dimensional optical angiography". Optics Express. 15 (7): 4083–4097. Bibcode:2007OExpr..15.4083W. doi: 10.1364/OE.15.004083 . PMID   19532651.
  46. ↑ Gass JD, Sever RJ, Sparks D, Goren J (October 1967). "A combined technique of fluorescein funduscopy and angiography of the eye". Archives of Ophthalmology. 78 (4): 455–461. doi:10.1001/archopht.1967.00980030457009. PMID   6046840.
  47. ↑ Slakter JS, Yannuzzi LA, Guyer DR, Sorenson JA, Orlock DA (June 1995). "Indocyanine-green angiography". Current Opinion in Ophthalmology. 6 (3): 25–32. doi:10.1097/00055735-199506000-00005. PMID   10151085. S2CID   43888613.
  48. ↑ Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E (May 1986). "Fluorescein angiography complication survey". Ophthalmology. 93 (5): 611–617. doi:10.1016/s0161-6420(86)33697-2. PMID   3523356.
  49. ↑ "Fluorescein Angiography". American Academy of Ophthalmolog. Archived from the original on 27 May 2016.
  50. ↑ Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, et al. (2012). "A review of indocyanine green fluorescent imaging in surgery". International Journal of Biomedical Imaging. 2012: 940585. doi: 10.1155/2012/940585 . PMC   3346977 . PMID   22577366.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.